SOPHYSA – Trademark Portfolio
Entity Type: 99
SOPHYSA holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 10 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 5 Nice Classification classes. Currently, 4 trademarks are registered and 3 are pending. Notable registered marks include POLARIS, PRESSIO, SOPHYSA, and AT THE HEART OF THE BRAIN. The owner is based in F-91400 ORSAY.
Parc Club Orsay Université
22, rue Jean Rostand
F-91400 ORSAY , FR
Showing of trademarks Trademarks
Trademark Classifications
SOPHYSA's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does SOPHYSA have?
SOPHYSA has 11 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 pending, 2 abandoned.
What trademark classes does SOPHYSA file in?
SOPHYSA files trademarks across 5 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 37 (Building & Construction), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are SOPHYSA's most well-known trademarks?
SOPHYSA's registered trademark portfolio includes well-known marks such as POLARIS, PRESSIO, SOPHYSA, and AT THE HEART OF THE BRAIN. These are among 4 currently registered trademarks in the portfolio.
What is SOPHYSA's trademark registration success rate?
SOPHYSA has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 3 applications are pending review.